Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ofatumumab> ?p ?o. }
Showing items 1 to 74 of
74
with 100 items per page.
- Ofatumumab abstract "Ofatumumab (trade name Arzerra, also known as HuMax-CD20) is a humanized monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and has also shown potential in treating Follicular non-Hodgkin’s lymphoma, Diffuse large B cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis. Ofatumumab has also received conditional approval in Europe for the treatment of refractory chronic lymphocytic leukemia. This makes ofatumumab the first marketing application for an antibody produced by Genmab, as well as the first human monoclonal antibody which targets the CD20 molecule that will be available for patients with refractory CLL.".
- Ofatumumab atcPrefix "L01".
- Ofatumumab atcSuffix "XC10".
- Ofatumumab casNumber "679818-59-8".
- Ofatumumab fdaUniiCode "M95KG522R0".
- Ofatumumab wikiPageExternalLink results?term=HuMax-CD20.
- Ofatumumab wikiPageExternalLink pmidlookup?view=long&pmid=18003886.
- Ofatumumab wikiPageExternalLink abstract.php?id=8895.
- Ofatumumab wikiPageID "9700674".
- Ofatumumab wikiPageRevisionID "606063847".
- Ofatumumab atcPrefix "L01".
- Ofatumumab atcSuffix "XC10".
- Ofatumumab c "6480".
- Ofatumumab casNumber "679818".
- Ofatumumab chembl "1201836".
- Ofatumumab chemspiderid "NA".
- Ofatumumab eliminationHalfLife "1209600.0".
- Ofatumumab h "10022".
- Ofatumumab hasPhotoCollection Ofatumumab.
- Ofatumumab legalUk "POM".
- Ofatumumab legalUs "Rx-only".
- Ofatumumab licenceEu "Arzerra".
- Ofatumumab licenceUs "Ofatumumab".
- Ofatumumab mabType "mab".
- Ofatumumab medlineplus "a610009".
- Ofatumumab molecularWeight "146.1".
- Ofatumumab n "1742".
- Ofatumumab o "2020".
- Ofatumumab pregnancyUs "C".
- Ofatumumab routesOfAdministration "IV".
- Ofatumumab s "44".
- Ofatumumab source "u".
- Ofatumumab target CD20.
- Ofatumumab tradename "Arzerra".
- Ofatumumab type "mab".
- Ofatumumab unii "M95KG522R0".
- Ofatumumab verifiedfields "changed".
- Ofatumumab verifiedrevid "458269271".
- Ofatumumab subject Category:Monoclonal_antibodies_for_tumors.
- Ofatumumab type Abstraction100002137.
- Ofatumumab type Antibody115027189.
- Ofatumumab type Chemical114806838.
- Ofatumumab type Compound114818238.
- Ofatumumab type Macromolecule114944888.
- Ofatumumab type Material114580897.
- Ofatumumab type Matter100020827.
- Ofatumumab type Molecule114682133.
- Ofatumumab type MonoclonalAntibodiesForTumors.
- Ofatumumab type MonoclonalAntibody115029781.
- Ofatumumab type OrganicCompound114727670.
- Ofatumumab type Part113809207.
- Ofatumumab type PhysicalEntity100001930.
- Ofatumumab type Protein114728724.
- Ofatumumab type Relation100031921.
- Ofatumumab type Substance100019613.
- Ofatumumab type Thing100002452.
- Ofatumumab type Unit109465459.
- Ofatumumab type Drug.
- Ofatumumab type DrugProduct.
- Ofatumumab type FunctionalSubstance.
- Ofatumumab comment "Ofatumumab (trade name Arzerra, also known as HuMax-CD20) is a humanized monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and has also shown potential in treating Follicular non-Hodgkin’s lymphoma, Diffuse large B cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis.".
- Ofatumumab label "Ofatumumab".
- Ofatumumab label "Ofatumumab".
- Ofatumumab label "Ofatumumab".
- Ofatumumab label "Ofatumumab".
- Ofatumumab sameAs Ofatumumab.
- Ofatumumab sameAs Ofatumumab.
- Ofatumumab sameAs Ofatumumab.
- Ofatumumab sameAs m.02ppkkv.
- Ofatumumab sameAs Q410656.
- Ofatumumab sameAs Q410656.
- Ofatumumab sameAs Ofatumumab.
- Ofatumumab wasDerivedFrom Ofatumumab?oldid=606063847.
- Ofatumumab isPrimaryTopicOf Ofatumumab.